Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | tyrosin kinase, putative | 0.0015 | 0.0274 | 1 |
Echinococcus multilocularis | hypothetical protein | 0.0025 | 0.1032 | 0.4062 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.1032 | 0.5944 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1737 | 0.1737 |
Echinococcus granulosus | semaphorin 5B | 0.0025 | 0.1032 | 0.4062 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0015 | 0.0274 | 1 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0025 | 0.1032 | 0.1032 |
Echinococcus granulosus | plexin a4 | 0.0046 | 0.2542 | 1 |
Echinococcus multilocularis | neuroglian | 0.0011 | 0.0013 | 0.0052 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Loa Loa (eye worm) | plexin A | 0.0046 | 0.2542 | 0.2542 |
Echinococcus granulosus | semaphorin 1A | 0.0025 | 0.1032 | 0.4062 |
Echinococcus multilocularis | roundabout 2 | 0.0014 | 0.0226 | 0.0887 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0012 | 0.0059 | 0.0233 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0226 | 0.0226 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Brugia malayi | plexin A | 0.0046 | 0.2542 | 0.2542 |
Echinococcus granulosus | neuroglian | 0.0011 | 0.0013 | 0.0052 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0011 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0226 | 0.0226 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0149 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0 | 0.5 |
Schistosoma mansoni | nephrin | 0.0011 | 0.0013 | 0.0075 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0011 | 0 | 0.5 |
Onchocerca volvulus | 0.0133 | 0.8861 | 0.9467 | |
Echinococcus multilocularis | semaphorin 5B | 0.0025 | 0.1032 | 0.4062 |
Echinococcus multilocularis | plexin a4 | 0.0046 | 0.2542 | 1 |
Echinococcus granulosus | roundabout 2 | 0.0014 | 0.0226 | 0.0887 |
Onchocerca volvulus | 0.0035 | 0.1737 | 0.0852 | |
Loa Loa (eye worm) | sema domain-containing protein | 0.0025 | 0.1032 | 0.1032 |
Brugia malayi | Plexin repeat family protein | 0.0035 | 0.1737 | 0.1737 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.1032 | 0.5944 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0011 | 0 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0011 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0025 | 0.1032 | 0.1032 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0059 | 0.0059 |
Brugia malayi | Sema domain containing protein | 0.0025 | 0.1032 | 0.1032 |
Schistosoma mansoni | semaphorin 5-related | 0.0025 | 0.1032 | 0.5944 |
Schistosoma mansoni | cell adhesion molecule | 0.0012 | 0.0059 | 0.0341 |
Echinococcus granulosus | twitchin | 0.0011 | 0.0013 | 0.0052 |
Schistosoma mansoni | plexin | 0.0035 | 0.1737 | 1 |
Brugia malayi | Sema domain containing protein | 0.0025 | 0.1032 | 0.1032 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0011 | 0 | 0.5 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0139 | 0.9302 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.471 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.371 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.277 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.235 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.